News Agency
The Times

Eluminex Biosciences Announces Completion of Initial Enrollment in Part A of the CLARITY Study Evaluating a Human Recombinant Collagen-derived (rhCIII) Biosynthetic Cornea (EB-301)

  • Written by PR Newswire

Initial Part A results to be presented at the upcoming American Society of Cataract and Refractive Surgery Annual Meeting

EB-301 has the potential to be the world's first approved rhCIII biosynthetic corneal implant for the treatment of corneal blindness

SUZHOU, China and SAN FRANCISCO, Feb. 15, 2023 /PRNewswire/ -- Eluminex Biosciences today...

Read more: Eluminex Biosciences Announces Completion of Initial Enrollment in Part A of the CLARITY Study...

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion